ATHROMBIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Athrombin, and when can generic versions of Athrombin launch?
Athrombin is a drug marketed by Pharm Res Assoc and is included in one NDA.
The generic ingredient in ATHROMBIN is warfarin potassium. There are two drug master file entries for this compound. Additional details are available on the warfarin potassium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ATHROMBIN?
- What are the global sales for ATHROMBIN?
- What is Average Wholesale Price for ATHROMBIN?
Summary for ATHROMBIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 64 |
| Patent Applications: | 8,101 |
| DailyMed Link: | ATHROMBIN at DailyMed |
US Patents and Regulatory Information for ATHROMBIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharm Res Assoc | ATHROMBIN | warfarin sodium | TABLET;ORAL | 011771-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharm Res Assoc | ATHROMBIN-K | warfarin potassium | TABLET;ORAL | 011771-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharm Res Assoc | ATHROMBIN-K | warfarin potassium | TABLET;ORAL | 011771-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharm Res Assoc | ATHROMBIN | warfarin sodium | TABLET;ORAL | 011771-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharm Res Assoc | ATHROMBIN | warfarin sodium | TABLET;ORAL | 011771-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
